Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
NCT ID: NCT01648309
Last Updated: 2016-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2012-09-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators plan to include all patients planned to have TAVI in the study and to test them before, 3,7, 30 and 360 days post TAVI with a standardized battery of test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurocognitive Assessment in TAVI
NCT06120946
Cardiac Output, Cerebral Perfusion and Cognition in Patients Undergoing TAVI
NCT05481008
Cognitive Outcome After Surgical and Transcatheter Aortic Valve Replacement
NCT04535076
Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
NCT02023060
Pilot Study of Cognitive and Functional Outcomes Following TAVI
NCT02089945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAVI
patients with significant aortic stenosis that are candidates for transvascular aortic valve implantation
Neuropsychological testing
This is an observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuropsychological testing
This is an observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to perform the testing
* Able to sign informed consent
Exclusion Criteria
* Existing dementia
* Existing disease limiting life expectancy to less than 180 days
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ronen Leker
Director - Stroke Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronen R Leker, MD
Role: PRINCIPAL_INVESTIGATOR
Hadassah Medical Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Medical Center
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TAVI registry Hadassah
Identifier Type: -
Identifier Source: secondary_id
TAVI registry Hadassah
Identifier Type: REGISTRY
Identifier Source: secondary_id
TAVIPSYCH-HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.